Amino acid signatures in relation to polycystic ovary syndrome and increased risk of different metabolic disturbances
Authors:
- Yue ZhaoYZYue Zhao
- Jie QiaoJQJie Qiao
- 1 April 2022
- journal article
- research article
- Published by Elsevier in Reproductive BioMedicine Online
- Vol. 44 (4) , 737-746
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81601243, 81671419, 81871139)
- Chinese Academy of Meteorological Sciences (2019-I2M-5-001)
- National Key Research and Development Program of China (2017YFC1001003)
This publication has 44 references indexed in Scilit:
- Prevalence of polycystic ovary syndrome in women in China: a large community-based studyHuman Reproduction, 2013
- Metabolic profiles characterizing different phenotypes of polycystic ovary syndrome: plasma metabolomics analysisBMC Medicine, 2012
- Metabolomic biomarkers in women with polycystic ovary syndrome: a pilot studyMolecular Human Reproduction, 2012
- Metabolic Heterogeneity in Polycystic Ovary Syndrome Is Determined by Obesity: Plasma Metabolomic Approach Using GC-MSClinical Chemistry, 2012
- Metabonomics Reveals Plasma Metabolic Changes and Inflammatory Marker in Polycystic Ovary Syndrome PatientsJournal of Proteome Research, 2012
- Polycystic ovary syndrome: etiology, pathogenesis and diagnosisNature Reviews Endocrinology, 2011
- A Branched-Chain Amino Acid-Related Metabolic Signature that Differentiates Obese and Lean Humans and Contributes to Insulin ResistanceCell Metabolism, 2009
- Alanine aminotransferase isoenzymes: Molecular cloning and quantitative analysis of tissue expression in rats and serum elevation in liver toxicity #Hepatology, 2009
- Glutathione in Defense and SignalingAnnals of the New York Academy of Sciences, 2002
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001